Mark Diamond | Managing Director and CEO
Antisense Therapeutics Ltd | Australia

Mark Diamond, Managing Director and CEO, Antisense Therapeutics Ltd

Mark Diamond has over 30 years experience in the pharmaceutical and biotechnology industry. Before joining Antisense Therapeutics Limited as MD and CEO in 2001, Mr. Diamond was employed in the US as Director, Project Planning/Business Development at Faulding Pharmaceuticals. Prior to this he held the positions of Senior Manager, Business Development and In-licensing within Faulding’s European operation based in the UK and International Business Development Manager with Faulding in Australia.


Phar East 2020 Agenda Day One @ 11:30

ATL1102 for Duchenne muscular dystrophy (DMD)

last published: 09/Dec/20 03:45 GMT

back to speakers






For speaking, sponsorship and exhibition opportunities contact
Tel: +65 6322 2738